ArticleAnti-cancer drugs2026

The novel integrin-linked kinase inhibitor nilotinib suppresses cancer progression by promoting ubiquitylation of autoimmune regulator in oesophageal squamous cell carcinoma.

Xiaoli Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.